ArticleInternational neurourology journal2026
Male Hypogonadism and Lower Urinary Tract Symptoms: Testicular Volume as an Independent Predictor.
Article in International neurourology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Evolutionary Frontiers in Urology: Expanding Clinical Care Through Devices and Intelligence.International neurourology journal · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
purposeThe maximum urinary flow rate (Qmax) is the most clinically relevant uroflowmetry parameter and is strongly associated with the International Prostate Symptom Score. However, traditional predictors such as age, prostate volume, and voided volume (VV) only partially explain the wide variability in Qmax among men with lower urinary tract symptoms (LUTS). Given the recognized role of male hypogonadism in LUTS progression and the potential of testicular volume as a surrogate marker of long-term androgenic status, this study investigated whether testicular volume could serve as a novel predictor of Qmax.
methodsWe retrospectively analyzed 170 men with LUTS evaluated between April 2012 and March 2017. All patients underwent uroflowmetry, transrectal ultrasonography, and testicular volume assessment using a Prader orchidometer. Serum prostate-specific antigen and testosterone levels were measured. Pearson correlation analysis was used to explore associations between clinical variables and Qmax, followed by multivariate linear regression to identify independent predictors.
resultsThe mean age was 69.3 years, mean total prostate volume (TPV) 66.1 mL, and mean total testicular volume (TTV) 32.2 mL. In univariate analysis, age, height, TPV, TTV, VV, and residual urine (RU) were significantly correlated with Qmax. Multivariate regression demonstrated that TTV (β=0.268, P=0.001), VV (β=0.370, P<0.001), and RU (β=-0.193, P=0.009) were independent predictors, whereas prostate volume, age, and serum testosterone were not.
conclusionThe TTV is a novel independent predictor of Qmax in men with LUTS. Smaller testicular volume was associated with a lower rate of urinary flow, potentially reflecting the cumulative endocrine decline associated with male hypogonadism. As a simple and noninvasive measurement, TTV can serve as a valuable clinical marker to complement existing assessments, helping to identify patients at higher risk for poor voiding function and guiding further comprehensive evaluations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.